Chronic tophaceous gout presenting as acute arthritis during an acute illness: a case
report
Department of Internal Medicine, Michigan State University, East Lansing, Michigan, USA
author email corresponding author email
Cases Journal 2008, 1:238doi:10.1186/1757-1626-1-238
© 2008 Dhoble et al; licensee BioMed Central Ltd.
Gout is a metabolic disease that can manifest as acute or chronic arthritis, and deposition of urate crystals in
connective tissue and kidneys. It can either manifest as acute arthritis or chronic tophaceous gout.
Case presentation
We present a 39-year-old male patient who developed acute arthritis during his hospital course. Later on, after
a careful physical examination, patient was found to have chronic tophaceous gout. The acute episode was
successfully treated with colchicines and indomethacin.
Conclusion
Gout usually flares up during an acute illness, and should be considered while evaluating acute mono articular
arthritis. Rarely, it can also present with tophi as an initial manifestation.
Background
Gout is a metabolic disease, which is characterized by acute or chronic arthritis, and deposition of monosodium
urate crystals in joint, bones, soft tissues, and kidneys [1-4]. In 18th century, Garrod proposed a causative
relationship between elevated uric acid and urate crystal formation, which is underlying pathology for gout [4].
Gout can either manifest as acute arthritis or chronic arthropathy, which is also called tophaceous gout
[1,2,5].
Case presentation
A 39-year-old African American male patient was admitted with one-day history of acute left lower quadrant pain,
and was diagnosed with acute uncomplicated diverticulitis, confirmed by computed tomography (CT) of the abdomen.
His medical and surgical history was unremarkable, and he denied any medication use. He denied smoking or illicit
drug use, but admitted occasional alcohol use on every other weekend. He did not follow any particular diet. He had
an average built with BMI of 29.6. He was started on intravenous antibiotics and pain medication, which led to
significant clinical improvement within two days.
On the third day of hospitalization, he developed acute, severe pain and swelling of the left elbow. Within next
few hours, pain worsened and he was unable to move the elbow joint, which was tender, erythematous, and swollen on
examination (figure 1). Never investigated in the past, we also noted a firm 4 × 6 cm mass on each elbow, and
another one surrounding the proximal inter-phalangeal joint of right middle finger (figure 2). There was no
overlying edema or cellulitis. There were no other swellings or tophi noted especially on toes or ears. When asked
particularly, he denied similar episodes in the past. He also denied any episode of swelling of great toe in the
past.
thumbnailFigure 1. Tophus at the back of right elbow.
thumbnailFigure 2. Tophi/tophus around the proximal inter-phalangeal joint of right middle finger.
Plain radiography of left elbow showed joint effusion, and soft tissue swelling. Radiography of other joints
including hands and feet was not performed. Laboratory values on the third day are given in table 1. Liver function
test was also performed, and the results were unremarkable. Diagnostic arthocentesis was performed on both the
elbows, and revealed negatively birefringent needle-shaped crystals using polarized microscopy in both samples.
Detailed analysis of synovial fluid is given in table 2. The swelling on the right elbow was aspirated to determine
the etiology because patient had that swelling for a long time.
Table 1. Laboratory values at admission.
Table 2. Synovial fluid analysis.
The patient responded partially to colchicine, but later had great relief with indomethacin. Colchicine was used
at the dose of 0.6 mg every two hourly. He received total of six doses, but it was stopped because he developed
severe nausea and vomiting. He admitted that his pain was reduced to 4/10 in intensity from 9/10 before treatment,
but swelling was persistent. We initiated indomethacin at 50 mg every eight hourly, and his pain and swelling was
relieved to great extent in 48 hours.
Discussion
Gout is a metabolic disease that can manifest as acute or chronic arthritis, and deposition of urate crystals in
connective tissue and kidneys. All patients have hyperuricemia at some point of their disease. But, either normal
or low serum uric acid levels can occur at the time of acute attack; and asymptomatic hyperuricemic individuals may
never experience a clinical event resulting from urate crystal deposition [1-4]. Low to normal uric acid
concentration can be due to excessive excretion of uric acid, crystal formation, or systemic inflammatory state
[6,7]; however, exact mechanism is still not completely understood. A diagnosis of gout is most accurate when
supported by visualization of uric acid crystals in a sample of joint or bursal fluid, or demonstrated
histologically in excised tissue. Synovial fluid analysis of our patient was consistent with inflammatory
arthritis. Mild leucocytosis in this patient was due to systemic inflammatory response.
Visible or palpable tophi, as this patient exhibited, are usually noted only among those patients who are
hyperuricemic and have had repeated attacks of acute gout, often over many years. However, presentation of
tophaceous deposits in the absence of gouty arthritis is also reported [5,8]. Pain and inflammation are manifested
when uric acid crystals activate the humoral and cellular inflammatory processes [9].
During an acute illness, if systemic inflammatory state prevails, such as in an acute infection, cytokines and
chemokines triggers inflammation and cause arthritis in the presence of urate crystals [10,11]. Phagocytosis of
these crystals by macrophages in the synovial lining cells precedes influx of neutrophils in the joint [9-11]. This
process releases various mediators of inflammation locally [12,13].
Hyperuricemia is often present in patients with tophaceous gout, and they can benefit from uric acid lowering
therapy early during the course [14,15]. In our patient, serum uric acid and 24-hour urine uric acid level was
within normal limits when measured in the hospital before his discharge from the hospital. It was decided to follow
him up in the clinic in two weeks, and measure these values again during 'interval gout' before deciding to start
him on any particular medication to prevent further attacks of acute arthritis.
Our patient presented with tophi as an initial presentation of gout, which is very rare, but has been reported
[5,8]. Investigational studies due to acute elbow joint pain deciphered the underlying mystery of chronic swelling.
Systemic inflammatory response secondary to diverticulitis exposed the joints to the effects of urate.
First-line treatments for an acute flare are either oral colchicine and/or non-steroidal anti-inflammatory
agents. Systemic or intra-articular corticosteroids can also be used, and are equally effective, but with more side
effects [16,17]. Interleukin-1 inhibitors are still under investigation, and are not approved for an acute attack
of gout [18].
Conclusion
Gout usually flares up during an acute illness, and should always be considered while evaluating acute mono
articular arthritis in hospitalized patients. Gout can present with tophi as an initial manifestation of the
disease process.
|